BioMed Research International

BioMed Research International / 2002 / Article

Review article | Open Access

Volume 2 |Article ID 653162 | https://doi.org/10.1155/S1110724302204015

William L. Rust, Stephen W. Carper, George E. Plopper, "The Promise of Integrins as Effective Targets for Anticancer Agents", BioMed Research International, vol. 2, Article ID 653162, 7 pages, 2002. https://doi.org/10.1155/S1110724302204015

The Promise of Integrins as Effective Targets for Anticancer Agents

Received28 Jan 2002
Revised27 Mar 2002
Accepted28 Mar 2002

Abstract

This review will briefly describe integrin function, address why integrins are attractive targets for chemotherapeutic drug design, and discuss some ongoing studies aimed at inhibiting integrin activity. Integrins are cell surface heterodimeric receptors. They modulate many cellular processes including: growth, death (apoptosis), adhesion, migration, and invasion by activating several signaling pathways. Many potential chemotherapeutic agents target integrins directly (eg, polypeptides, monoclonal antibodies, adenovirus vectors). These agents may be clinically useful in controlling the metastatic spread of cancer.

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views94
Downloads273
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.